Shreeram Aradhye

2020

In 2020, Shreeram Aradhye earned a total compensation of $2.5M as Executive Vice President and Chief Medical Officer at Dicerna Pharmaceuticals.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$168,750
Option Awards$1,587,431
Salary$157,197
Stock Awards$525,189
Other$8,451
Total$2,547,018

Aradhye received $1.6M in option awards, accounting for 62% of the total pay in 2020.

Aradhye also received $100K in bonus, $168.8K in non-equity incentive plan, $157.2K in salary, $525.2K in stock awards and $8.5K in other compensation.

Rankings

In 2020, Shreeram Aradhye's compensation ranked 4,462nd out of 13,090 executives tracked by ExecPay. In other words, Aradhye earned more than 65.9% of executives.

ClassificationRankingPercentile
All
4,462
out of 13,090
66th
Division
Manufacturing
1,807
out of 5,621
68th
Major group
Chemicals And Allied Products
702
out of 2,254
69th
Industry group
Drugs
601
out of 1,954
69th
Industry
Pharmaceutical Preparations
456
out of 1,459
69th

Pay ratio

Shreeram Aradhye's Pay$2,547,018
Median Employee's Pay$311,375
Pay Ratio

8

to 1

In 2020, the annual total compensation of Shreeram Aradhye was $2,547,018.

The annual total compensation of the median employee at Dicerna Pharmaceuticals was $311,375.

The ratio of Shreeram Aradhye's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 20, 2021.

Aradhye's colleagues

We found six more compensation records of executives who worked with Shreeram Aradhye at Dicerna Pharmaceuticals in 2020.

2020

Douglas Fambrough

Dicerna Pharmaceuticals

Chief Executive Officer

2020

Ralf Rosskamp

Dicerna Pharmaceuticals

Chief Medical Officer

2020

John Green

Dicerna Pharmaceuticals

Chief Financial Officer

2020

Bob Brown

Dicerna Pharmaceuticals

Chief Scientific Officer

2020

James Weissman

Dicerna Pharmaceuticals

Chief Operating Officer

2020

Douglas Pagán

Dicerna Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like